Xenon Pharmaceuticals Inc (XENE) is a publicly traded Healthcare sector company. As of November 2, 2026, XENE trades at $36.95 with a market cap of $3.62B and a P/E ratio of -8.34. XENE moved +0.48% today. Year to date, XENE is -15.46%; over the trailing twelve months it is -10.28%. Its 52-week range spans $26.74 to $72.66. Analyst consensus is strong buy with an average price target of $70.54. Rallies surfaces XENE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for XENE combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $36.95 |
| Market Cap | $3.62B |
| P/E Ratio | -8.34 |
| EPS | $-4.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $72.66 |
| 52-Week Low | $26.74 |
| Volume | 2.11M |
| Avg Volume | 0 |
| Revenue (TTM) | $7.50M |
| Net Income | $-345.91M |
| Gross Margin | 0.00% |
16 analysts cover XENE: 0 strong buy, 15 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $70.54.